News | May 17, 2024
Cresset opens new new India HQ in Bengaluru to tap potential of APAC market
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Achira is engaged in development and commercialization of PoC medical test kits in India
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Lupin updates on shipment of Mirabegron ER Tablets
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Subscribe To Our Newsletter & Stay Updated
